Rafarma Pharmaceuticals, Inc. RAFA
Set alert
0.02 USD 0.00 -15.00%
At close · Oct 30
0.0165 Day range 0.0175
0.004 52-week range 0.093
- YTD
- -37.04%
- 1 year
- -56.41%
- Open
- 0.0175
- Prev close
- 0.02
- Mkt cap
- 1.49M
- Vol
- 10.00K
- Avg vol
- 13.41K
- EPS
- -0.014
- P/E
- 0.00
More statistics
- Low
- 0.0165
- High
- 0.0175
3M chart
Signals (18)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 3 days ago |
| RSI: Oversold | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 25, 2026 | 1 month ago |
| RSI: Overbought | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
News
- Rafarma Pharmaceuticals to Present at the Virtual Life Science Investor Forum March 13th
- Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea
- Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care
- Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
- Rafarma Pharmaceutical news update
- Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
- Letter to Shareholders from the Chairman of the Board Ilya Shpurov
- Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build
- Rafarma's Global Pharmaceutical Strategy At A Glance
- Rafarma To Expand Proton Therapy Centers
Your note
Sign in to keep a note on RAFA — it syncs with the Stock Master app.